Suppr超能文献

腺苷和α-2-肾上腺素能受体拮抗剂可逆转替扎尼定对DBA/2小鼠的抗惊厥作用。

Antagonists of adenosine and alpha-2-adrenoceptors reverse the anticonvulsant effects of tizanidine in DBA/2 mice.

作者信息

De Sarro G B, De Sarro A

机构信息

Institute of Pharmacology, University of Reggio Calabria, Italy.

出版信息

Neuropharmacology. 1989 Mar;28(3):211-5. doi: 10.1016/0028-3908(89)90095-6.

Abstract

The anticonvulsant activity of 5-chloro-4-(2-imidazolin-2yl-amino)-2,1,3-benzothiazole, tizanidine, was studied following intraperitoneal (i.p.) administration in DBA/2 mice (which show sound-induced seizures). Protection against sound-induced seizures was observed after tizanidine, (0.5-4 mg/kg i.p.). The ED50 values for suppression of the tonic, clonic and wild running phases of sound-induced seizures were 0.54, 0.76 and 1.43 mg/kg, respectively. This protective action was significantly reduced by pretreatment with aminophylline (25 mg/kg i.p.), yohimbine (1 mg/kg i.p.) or piperoxan (20 mg/kg i.p.). Methysergide, a serotonin antagonists, did not significantly reduce the anticonvulsant effects of tizanidine. The present experiments suggest an involvement of purinergic and adrenergic mechanisms in the anticonvulsant action of tizanidine.

摘要

研究了5-氯-4-(2-咪唑啉-2-基氨基)-2,1,3-苯并噻唑(替扎尼定)在DBA/2小鼠(表现出声音诱发惊厥)腹腔注射后的抗惊厥活性。腹腔注射替扎尼定(0.5 - 4毫克/千克)后,观察到对声音诱发惊厥的保护作用。抑制声音诱发惊厥的强直、阵挛和狂奔阶段的半数有效量(ED50)值分别为0.54、0.76和1.43毫克/千克。用氨茶碱(25毫克/千克腹腔注射)、育亨宾(1毫克/千克腹腔注射)或哌罗克生(20毫克/千克腹腔注射)预处理可显著降低这种保护作用。5-羟色胺拮抗剂麦角新碱并未显著降低替扎尼定的抗惊厥作用。本实验表明嘌呤能和肾上腺素能机制参与了替扎尼定的抗惊厥作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验